Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
Earnings
2026
Earnings, Q1 FY2026
May 21, 2026
Profit after tax more than doubled year-over-year, with EPS rising to €0.166.
2025
Earnings, Q4 FY2025
Annual
Mar 23, 2026
2025 net turnover rose 17.3% to €1.94M, but profit fell to €29.1K; dividend payout proposed.
Earnings, Q3 FY2025
Nov 20, 2025
Net sales, profit, and EPS rose year-over-year, with improved equity and cash flow.
Earnings, Q2 FY2025
Aug 21, 2025
Net turnover grew 24.5% year-over-year, but profit before tax fell 6% to €57.7k.
Earnings, Q1 FY2025
May 22, 2025
Net sales up 24% and net profit increased, but operating cash flow turned negative.
2024
Earnings, Q4 FY2024
Annual
Mar 24, 2025
2024 net profit rose 23.5% to €80.8k, driven by genetics sales growth and stable operations.
Earnings, Q3 FY2024
Nov 21, 2024
Net sales rose 6% but net profit and EPS declined for the nine months of 2024.
Earnings, Q2 FY2024
Aug 22, 2024
Net turnover up 1% to €768.3k, but profit before tax down 27.6% to €61.4k.